Literature DB >> 23514347

Opportunities for public health communication, intervention, and future research on breast cancer in younger women.

Natasha Buchanan1, Katherine B Roland, Juan L Rodriguez, Jacqueline W Miller, Temeika Fairley.   

Abstract

BACKGROUND: Approximately 6% of breast cancers in the United States occur in women under the age of 40 years. Compared with women ≥40 years of age, younger women are diagnosed at later stages, have higher rates of recurrence and death, and may be predisposed to secondary breast or ovarian cancer. An informal meeting of experts discussed opportunities for research and public health communication related to breast cancer among young (<40 and/or premenopausal) women.
METHODS: In September 2011, the Centers for Disease Control and Prevention hosted 18 experts in oncology, genetics, behavioral science, survivorship and advocacy, public health, communication, ethics, nutrition, physical activity, and environmental health. They (1) reviewed research and programmatic knowledge on risk and preventive factors, early detection, and survivorship; and (2) discussed ideas for research, communication, and programmatic efforts related to young women diagnosed with or at risk for early onset breast cancer.
RESULTS: Levels of evidence and themes for future research regarding risk and preventive factors, including exposures, were discussed. Early detection strategies, including screening, risk assessment, and genetic counseling, as well as survivorship issues, follow-up care, fertility and reproductive health, and psychosocial care were highlighted.
CONCLUSION: Community and academic researchers, providers, advocates, and the federal public health community discussed strategies and opportunities for this unique population. Although the evidence is limited, future research and communication activities may be useful to organize future public health initiatives.

Entities:  

Mesh:

Year:  2013        PMID: 23514347      PMCID: PMC4486009          DOI: 10.1089/jwh.2012.4239

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  13 in total

1.  Breast cancer racial differences before age 40--implications for screening.

Authors:  Edwin T Johnson
Journal:  J Natl Med Assoc       Date:  2002-03       Impact factor: 1.798

2.  Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.

Authors:  Bo Yu; Nataki Douglas; Michel J Ferin; Gary S Nakhuda; Katherine Crew; Rogerio A Lobo; Dawn L Hershman
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

Review 3.  Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Durado Brooks; Debbie Saslow; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2010 Mar-Apr       Impact factor: 508.702

4.  Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.

Authors:  Diana S M Buist; Linn A Abraham; William E Barlow; Arun Krishnaraj; Regan C Holdridge; Edward A Sickles; Patricia A Carney; Karla Kerlikowske; Berta M Geller
Journal:  Breast Cancer Res Treat       Date:  2010-08-11       Impact factor: 4.872

Review 5.  Breast cancer screening among women younger than age 50: a current assessment of the issues.

Authors:  R A Smith
Journal:  CA Cancer J Clin       Date:  2000 Sep-Oct       Impact factor: 508.702

Review 6.  Fertility and reproductive considerations in premenopausal patients with breast cancer.

Authors:  M Catherine Lee; Jhanelle Gray; Hyo Sook Han; Shayne Plosker
Journal:  Cancer Control       Date:  2010-07       Impact factor: 3.302

7.  The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.

Authors:  Mary E Abusief; Stacey A Missmer; Elizabeth S Ginsburg; Jane C Weeks; Ann H Partridge
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

8.  Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.

Authors:  Jennifer L Gnerlich; Anjali D Deshpande; Donna B Jeffe; Allison Sweet; Nick White; Julie A Margenthaler
Journal:  J Am Coll Surg       Date:  2009-01-21       Impact factor: 6.113

9.  Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms.

Authors:  Sandra A Norman; A Russell Localio; Sheryl L Potashnik; Heather A Simoes Torpey; Michael J Kallan; Anita L Weber; Linda T Miller; Angela Demichele; Lawrence J Solin
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

10.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Yuelin Li; Charlotte T Furstenberg; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

View more
  3 in total

1.  Inhibitory effects of O-methylated isoflavone glycitein on human breast cancer SKBR-3 cells.

Authors:  Bo Zhang; Jun-Ping Su; Yang Bai; Jie Li; Yong-Hong Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

2.  Public Health Action Model for Cancer Survivorship.

Authors:  Angela R Moore; Natasha D Buchanan; Temeika L Fairley; Judith Lee Smith
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

3.  TP53 rs1042522 polymorphism and early-onset breast cancer.

Authors:  Irmak Icen-Taskin; Sevgi Irtegun-Kandemir; Omer Munzuroglu
Journal:  J Res Med Sci       Date:  2020-03-18       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.